GGrantIndex
← Leaderboards

Arum Han

Texas Engineering Experiment Station

Google Scholar ↗PubMed ↗ORCID ↗
$8,262,649
Attributed
$13,922,679
Total exposure
13
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY2007–25
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,949,326 · 14

By mechanism

R01$6,029,114 · 2
U2C$3,026,647 · 1
UH3$2,731,098 · 2
R21$1,973,057 · 5
UG3$1,491,871 · 1
P42$855,312 · 2

Top collaborators

Most similar at Texas Engineering Experiment Station

Same institution · by research overlap

Others in their field

Top investigators on “Cells”

Research focus

CellsResponseIn VitroDevicesCostTechnologyEnvironmentPremature BirthFetal MembranesTissuesInfectionPregnancyIn UteroDesignInnovationMembraneSuccessMicrofluidicsStructureFetusInflammationLeadFetalKinetics

Grant awards (38)

A Translational Center for Microphysiological Systems-Based Drug Development Tools for Pregnancy and Women's Health$1,496,973
U2C · FY2025 · TR
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$743,099
UH3 · FY2025 · TR · contact PI
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth$233,262
UH3 · FY2025 · TR
Project 3$211,535
P42 · FY2025 · ES · contact PI
A Translational Center for Microphysiological Systems-Based Drug Development Tools for Pregnancy and Women's Health$1,529,674
U2C · FY2024 · TR
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$749,159
UH3 · FY2024 · TR · contact PI
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$435,534
R01 · FY2024 · HD
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth$234,053
UH3 · FY2024 · TR
Project 3$208,250
P42 · FY2024 · ES · contact PI
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$771,525
UH3 · FY2023 · TR · contact PI
Development of a High-Throughput Microfluidics-Enabled Functional Assay for Rapidly Identifying Neutralizing Antibodies$521,618
R01 · FY2023 · AI
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$439,932
R01 · FY2023 · HD
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth$412,626
UH2 · FY2023 · TR
Project 3$212,921
P42 · FY2023 · ES · contact PI
Development of a High-Throughput Microfluidics-Enabled Functional Assay for Rapidly Identifying Neutralizing Antibodies$131,541
R01 · FY2023 · AI
Development of a High-Throughput Microfluidics-Enabled Functional Assay for Rapidly Identifying Neutralizing Antibodies$653,159
R01 · FY2022 · AI
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$439,932
R01 · FY2022 · HD
3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth$429,601
UH2 · FY2022 · TR
Project 3$222,606
P42 · FY2022 · ES · contact PI
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$722,985
UG3 · FY2021 · TR · contact PI
Development of a High-Throughput Microfluidics-Enabled Functional Assay for Rapidly Identifying Neutralizing Antibodies$707,436
R01 · FY2021 · AI
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$444,593
R01 · FY2021 · HD
Accelerating discovery of neutralizing paratopes with Functional Antibody Screening Technology$189,375
R21 · FY2021 · AI · contact PI
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$77,866
UG3 · FY2021 · TR · contact PI
Development of a High-Throughput Microfluidics-Enabled Functional Assay for Rapidly Identifying Neutralizing Antibodies$719,651
R01 · FY2020 · AI
Developing extracellular vesicle based therapeutics against pre-term birth through the use of maternal-fetal interface on a chip$691,020
UG3 · FY2020 · TR · contact PI
Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$552,500
R01 · FY2020 · HD
Administrative Supplement to Intercellular interactions define cell migrations and transitions that maintain fetal membrane homeostasis$280,934
R01 · FY2020 · HD
Accelerating discovery of neutralizing paratopes with Functional Antibody Screening Technology$225,750
R21 · FY2020 · AI
MIRROR: A Chip-Scale Mid-IR Ring Resonance System for On-the-fly Reporting of Analytes$176,043
R21 · FY2020 · GM · contact PI
Development of a High-Throughput Microfludics-Enabled Functional Assay for Rapidly Identifying Neutralizing Antibodies$702,284
R01 · FY2019 · AI
MIRROR: A Chip-Scale Mid-IR Ring Resonance System for On-the-fly Reporting of Analytes$215,831
R21 · FY2019 · GM · contact PI
A High-Throughput Microfluidic in vitro CNS Myelination Model towards Drug Screening$216,344
R21 · FY2016 · EB · contact PI
A High-Throughput Microfluidic in vitro CNS Myelination Model towards Drug Screening$179,524
R21 · FY2015 · EB · contact PI
CNS Myelination Co-Culture Microsystem for Axon-Gila Signaling$176,450
R21 · FY2010 · MH · contact PI
CNS Myelination Co-Culture Microsystem for Axon-Gila Signaling$210,603
R21 · FY2009 · MH · contact PI
An Integrated Microfluidic Cryo-Cooling System for MR Microcoils$207,544
R21 · FY2008 · EB · contact PI
An Integrated Microfluidic Cryo-Cooling System for MR Microcoils$175,593
R21 · FY2007 · EB · contact PI